- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Lymphoma, T-Cell, Peripheral
Medical specialists from France tagged as investigators in clinical trials studying Lymphoma, T-Cell, Peripheral
Total 59 results
-
Adele DE MASSONSeen in:
- Paris, Hôpital Saint louis
Trials:- NCT05886478 (Principal Investigator)
Conditions: -
Agathe WAULTIER - RASCALOUSeen in:
- Nîmes, CHU de Nîmes - Hôpital Caremeau
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Ahmad AL JIJAKLISeen in:
- Argenteuil, CH Victor Dupouy
- Argenteuil, FR-Argenteuil-CHARGENTEUIL
Trials:- NCT04027309 (Principal Investigator)
- NCT05444712 (Principal Investigator)
-
Aline CLAVERTSeen in:
- Angers, CHU d'Angers
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Ambroise MarcaisSeen in:
- Paris, FR-Paris cedex 15-NECKER
- Paris, Hopital Necker
Trials:- NCT04027309 (Principal Investigator)
- NCT05444712 (Principal Investigator)
- NCT05260528 (Principal Investigator)
-
ANNE-BENEDICTE DUVAL MODESTESeen in:
- Rouen, CHU Roeun
Trials:- NCT05886478 (Principal Investigator)
Conditions: -
Arthur DONYSeen in:
- Chambéry, Ch Metropole Savoie - Site Chambery
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Bénédicte DEAU-FISCHERSeen in:
- Paris, Hôpital Cochin
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Benoit TESSOULINSeen in:
- Nantes, CHU de Nantes
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Bernard DrenouSeen in:
- Other, Mulhouse, Hôpital Emile Muller
Trials:- NCT04569032 (Principal Investigator)
Conditions: -
Blandine BOUTINSeen in:
- Contamine sur Arve, CH Alpes Léman
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Caroline DELETTESeen in:
- Amiens, Chu D'Amiens - Hopital Sud
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Charles HERBAUXSeen in:
- Montpellier, CHU de Montpellier
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Charline MOULINSeen in:
- Vandœuvre-lès-Nancy, CHU Brabois
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Claire CALMETTESSeen in:
- Périgueux, Ch Perigueux
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Clémence SantanaSeen in:
- Lyon, Centre LEON BERARD
- Valence, CH de Valence
Trials:- NCT04797780 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions: -
Emmanuel BACHYSeen in:
- Other, Pierre Benite Cedex, Centre Hospitalier Lyon Sud
- Pierre Benite, CHU Lyon-Sud
Trials:- NCT05444712 (Principal Investigator)
- NCT04569032 (Principal Investigator)
Conditions: -
Franck MorschhauserSeen in:
- Dijon, René Olivier Casasnovas
- Lille, CHU Lille Service des Maladies du Sang
Trials:- NCT02576496 (Principal Investigator)
- NCT05444712 (Principal Investigator)
-
François LEMONNIERSeen in:
- Creteil, Hôpital Henri Mondor
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
François-Xavier GROSSeen in:
- Bordeaux, Chu de Bordeaux - Hopital Haut Leveque
- Pessac, CHU de Bordeaux - Hopital Haut-Lévêque
Trials:- NCT04531046 (Principal Investigator)
- NCT05444712 (Principal Investigator)
-
Frédéric PEYRADESeen in:
- Nice, Centre Antoine Lacassagne
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Gandhi L Damaj, MDSeen in:
- Caen, CHU de Caen
Trials:- NCT02576496 (Principal Investigator)
-
Hacène ZERAZHI, MDSeen in:
- Avignon, CH d'Avignon - Hopital Henri Duffaut
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Hugo LEGENDRESeen in:
- Saint-Pierre, Chu de La Reunion - Ghsr
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Jérôme CORNILLONSeen in:
- Saint-Priest-en-Jarez, Institut Cancerologie & Hematologie St-Etienne
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Julia HIEULLESeen in:
- Roubaix, Ch de Roubaix - Hopital Victor Provo
Trials:- NCT05444712 (Principal Investigator)
Conditions: -
Julie AbrahamSeen in:
- Limoges, Service Hématologie Clinique et Thérapie Cellulaire, CHU DE LIMOGES - HOPITAL DUPUYTREN,
- Other, Limoges Cedex, Centre Hospitalier Universitaire (CHU) De Limoges - Hopital Dupuytren
Trials:- NCT04404283 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions: -
Kamal BouabdallahSeen in:
- Pessac Cedex, Centre hospitalier universitaire de Haut Leveque
- Pessac, Hôpital Haut Lévêque
Trials:- NCT04662255 (Principal Investigator)
- NCT02576496 (Principal Investigator)
-
Kamal Krimo BouabdallahSeen in:
- Other, Pessac Cedex, CHU Bordeaux Hopital Haut-Leveque
- Other, Pessac, Groupe Hospitalier du Haut Leveque
Trials:- NCT04404283 (Principal Investigator)
- NCT04569032 (Principal Investigator)
Conditions:
Clinical Trials on Lymphoma, T-Cell, Peripheral
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsRecruitingPeripheral T Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma | Refractory T-Cell LymphomaChina
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
University of Alabama at BirminghamTerminatedAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Peripheral T-cell Lymphomas | Adult T-cell Leukemia | Adult T-cell Lymphoma | Peripheral T-cell Lymphoma Unspecified | T/Null Cell Systemic Type | Cutaneous t-Cell Lymphoma With Nodal/Visceral DiseaseUnited States
-
Legend Biotech USA IncActive, not recruitingT-Cell Lymphoma | Peripheral T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Recurrent | Peripheral T-Cell Lymphoma RecurrentUnited States
-
Karyopharm Therapeutics IncTerminatedCutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)Australia, Singapore
-
BeiGeneCompletedCutaneous T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extranodal NK/T-cell Lymphoma, Nasal Type | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Peripheral... and other conditionsChina, Taiwan, Germany, France, Canada, Italy
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAngioimmunoblastic T-cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | Follicular T-Cell Lymphoma | Nodal Peripheral T-Cell Lymphoma...United States
-
SciTech Development, LLCRush University Medical CenterRecruitingMycosis Fungoides | Cutaneous T-cell Lymphoma | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Cutaneous/Peripheral T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Classified | Primary Cutaneous T-cell Lymphoma | Cutaneous T-Cell Lymphoma, Unspecified | Follicular... and other conditionsUnited States